Abstract:In the example of a rat model with chronic hepatoencephalopathy (HE), changes in the organ morphology of rats affect the balance of metabolites of the tricarboxylic acid (TCA) cycle and metabolites of the glutamine–glutamate (Gln-Glu) cycle, namely α-ketoglutarate (αKG) and α-ketoglutaramate (αKGM), as well as the enzymes associated with them, ω-amidase (ωA) and glutamine transaminase (GTK). This model of rats was obtained as a result of 2–22 weeks of consumption by animals of hepatotoxin thioacetamide (TAA) added to drinking water at a concentration of 0.4 g/L. The control (n = 26) and TAA-induced (n = 55) groups of rats consisted of 11 cohorts each. The control cohorts consisted of 2–4 rats, and the TAA-induced cohorts consisted of 4–7 individuals. Every two weeks, samples of blood plasma, liver, kidney, and brain tissues were taken from the next cohort of rats (a total of 320 samples). By the end of the experiment, irreversible morphological changes were observed in the organs of rats: the weight of the animals was reduced up to ~45%, the weight of the kidneys up to 5%, the brain up to ~20%, and the weight of the liver increased up to ~20%. The analysis revealed: (i) a decrease in the activity of ωA and GTK in the tissues of the brain, kidneys, and liver of rats with chronic HE (by ~3, 40, and 65% and ~10, 60, and 70%, respectively); and (ii) the appearance of a significant imbalance in the content of metabolites of the Gln-Glu cycle, αKG, and αKGM. It is indicative that a ~1.5–12-fold increase in the level of αKG in the blood plasma and tissues of the organs of rats with chronic HE was accompanied by a synchronous, ~1.2–2.5-fold decrease in the level of αKGM. The data obtained indicate an essential involvement of the Gln-Glu cycle in the regulation of energy metabolism in rats under conditions of chronic HE. Attention is focused on the significance of the αKG/αKGM ratio, which can act as a potential marker for diagnosing the degree of HE development.

What problem does this paper attempt to address?

The problem that this paper attempts to solve is the changes of metabolites during the development of chronic hepatic encephalopathy (HE) and their relationship with disease progression. Specifically, the researchers focused on key metabolites in the tricarboxylic acid (TCA) cycle and the glutamine - glutamate (Gln - Glu) cycle, especially α - ketoglutarate (αKG) and α - ketoglutaramide (αKGM), as well as related enzymes such as ω - aminase (ωA) and glutamine transaminase (GTK) in evaluating the indication significance of chronic HE progression. The study explored how the changes of these metabolites and enzyme activities reflect the severity of the disease by using a thioacetamide (TAA) - induced rat model, and proposed that the αKG/αKGM ratio may be a potential marker for diagnosing the development degree of HE. ### Research Background Chronic hepatic encephalopathy (HE) is a neurological disease caused by alcohol or toxic cirrhosis, manifested as symptoms such as mood swings, depression, intellectual decline, and muscle hypotonia. The development of HE can be divided into five stages. As the disease progresses to stage III - IV, the patient's risk of death increases to nearly 70%. In the development of HE, the increase in ammonia level is an important factor, but ammonia is not the only triggering factor. The liver plays a key role in maintaining the ammonia balance in the blood, but in the case of hyperammonemia, the kidneys and the brain may also be involved in ammonia regulation. ### Research Methods The study used a TAA - induced rat model, adding TAA to the drinking water to simulate the development of human HE. The experiment lasted from 2 to 22 weeks and was divided into 11 cohorts. Samples, including plasma, liver, kidney, and brain tissues, were collected every two weeks for each cohort. The metabolite levels in the TCA cycle and the Gln - Glu cycle, as well as the activities of related enzymes, were analyzed by high - performance liquid chromatography (HPLC). ### Main Findings 1. **Metabolite Changes**: In the plasma and organ tissues of chronic HE rats, the αKG level increased significantly (about 1.5 - 12 times), while the αKGM level decreased synchronously (about 1.2 - 2.5 times). 2. **Enzyme Activity Changes**: In the brain, kidney, and liver tissues, the activities of ωA and GTK decreased by about 3%, 40%, 65% and 10%, 60%, 70% respectively. 3. **Pathological Changes**: As the experiment progressed, the body weight of rats decreased significantly (about 45%), the kidney weight decreased (about 5%), the brain weight decreased (about 20%), while the liver weight increased (about 20%). At the same time, the liver showed fibrosis, hematoma, and fatty degeneration, the kidney color became lighter, and the brain tissue softened. ### Conclusion The research results show that the ratio of αKG to αKGM (αKG/αKGM) can be used as a potential indicator for evaluating the progression of chronic HE. This finding is helpful for better understanding the pathogenesis of HE and provides new ideas for clinical diagnosis and treatment.

Energy Metabolites and Indicative Significance of α-Ketoglutarate and α-Ketoglutaramate in Assessing the Progression of Chronic Hepatoencephalopathy

NMDA Receptors and Indices of Energy Metabolism in Erythrocytes: Missing Link to the Assessment of Efficiency of Oxygen Transport in Hepatic Encephalopathy

Decreased glucose utilization in discrete brain regions of rat in thioacetamide-induced hepatic encephalopathy as measured with [3H]-deoxyglucose

Dynamic Alterations of Plasma Metabolites in the Progression of Liver Regeneration after Partial Hepatectomy.

Impaired Enzymatic Antioxidant Defense in Erythrocytes of Rats with Ammonia-Induced Encephalopathy: Role of NMDA Receptors

Is NMDA-Receptor-Mediated Oxidative Stress in Mitochondria of Peripheral Tissues the Essential Factor in the Pathogenesis of Hepatic Encephalopathy?

Hepatic encephalopathy as a result of ammonia-induced increase in GABAergic tone with secondary reduced brain energy metabolism

Acute Liver Failure in Rats Activates Glutamine-Glutamate Cycle but Declines Antioxidant Enzymes to Induce Oxidative Stress in Cerebral Cortex and Cerebellum

Analysis of time-related metabolic fluctuations induced by ethionine in the rat

Elucidating hippocampal proteome dynamics in moderate hepatic encephalopathy rats: insights from high-resolution mass spectrometry

Abnormal brain oxygen homeostasis in an animal model of liver disease

Feasibility exploration of GSH in the treatment of acute hepatic encephalopathy from the aspects of pharmacokinetics, pharmacodynamics, and mechanism

[Mitochondrial activities of citrate synthase, carnitine palmitoyltransferase-1 and cytochrome C oxidase are increased during the apoptotic process in hepatocytes of a rat model of acute liver failure].

An Integrated Metabonomic Approach to Describe Temporal Metabolic Disregulation Induced in the Rat by the Model Hepatotoxin Allyl Formate

Hyperammonemia in Hepatic Encephalopathy

Dynamic Changes of Key Metabolites During Liver Fibrosis in Rats.

High-fat high-fructose diet and alpha-ketoglutarate affect mouse behavior that is accompanied by changes in oxidative stress response and energy metabolism in the cerebral cortex

Hepatobiliary circulation and dominant urinary excretion of homogentisic acid in a mouse model of alkaptonuria

N-acetyl cysteine treatment preserves mitochondrial indices of functionality in the brain of hyperammonemic mice

Diffusion of brain metabolites highlights altered brain microstructure in type C hepatic encephalopathy: a 9.4 T preliminary study

Multiple ammonia-induced episodes of hepatic encephalopathy provoke neuronal cell loss in bile-duct ligated rats